BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 23467940)

  • 41. [Impacts of hypoxia on the features and chemoresistance of cancer stem cells in Hep-2 cells and underlying mechanism].
    Qu YT; Li XM; Xu O; Wang MX; Lu XY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Mar; 47(3):228-33. PubMed ID: 22805025
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibitory effects of epigallocatechin-3-gallate on cell proliferation and the expression of HIF-1α and P-gp in the human pancreatic carcinoma cell line PANC-1.
    Zhu Z; Wang Y; Liu Z; Wang F; Zhao Q
    Oncol Rep; 2012 May; 27(5):1567-72. PubMed ID: 22367292
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Knockdown of hypoxia-inducible factor-1 alpha by tumor targeted delivery of CRISPR/Cas9 system suppressed the metastasis of pancreatic cancer.
    Li M; Xie H; Liu Y; Xia C; Cun X; Long Y; Chen X; Deng M; Guo R; Zhang Z; He Q
    J Control Release; 2019 Jun; 304():204-215. PubMed ID: 31100311
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HIF-2α dictates the susceptibility of pancreatic cancer cells to TRAIL by regulating survivin expression.
    Harashima N; Takenaga K; Akimoto M; Harada M
    Oncotarget; 2017 Jun; 8(26):42887-42900. PubMed ID: 28476028
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of lentiviral vector-mediated RNA interference targeting hypoxia-inducible factor 1α on the uptake of fluorodeoxyglucose ((18)f) in the human pancreatic cancer cell line, patu8988.
    Fan G; Bo J; Wan R; Peng M; Luan Y; Deng M; Xu L
    Cancer Biother Radiopharm; 2015 May; 30(4):160-8. PubMed ID: 25853522
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Upregulation of autophagy by hypoxia-inducible factor-1α promotes EMT and metastatic ability of CD133+ pancreatic cancer stem-like cells during intermittent hypoxia.
    Zhu H; Wang D; Zhang L; Xie X; Wu Y; Liu Y; Shao G; Su Z
    Oncol Rep; 2014 Sep; 32(3):935-42. PubMed ID: 24994549
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Silencing of hypoxia inducible factor-1alpha by RNA interference attenuates human glioma cell growth in vivo.
    Gillespie DL; Whang K; Ragel BT; Flynn JR; Kelly DA; Jensen RL
    Clin Cancer Res; 2007 Apr; 13(8):2441-8. PubMed ID: 17438103
    [TBL] [Abstract][Full Text] [Related]  

  • 48. STAT3-targeting RNA interference inhibits pancreatic cancer angiogenesis in vitro and in vivo.
    Huang C; Jiang T; Zhu L; Liu J; Cao J; Huang KJ; Qiu ZJ
    Int J Oncol; 2011 Jun; 38(6):1637-44. PubMed ID: 21479358
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reciprocal loop of hypoxia-inducible factor-1α (HIF-1α) and metastasis-associated protein 2 (MTA2) contributes to the progression of pancreatic carcinoma by suppressing E-cadherin transcription.
    Zhu S; Deng S; He C; Liu M; Chen H; Zeng Z; Zhong J; Ye Z; Deng S; Wu H; Wang C; Zhao G
    J Pathol; 2018 Jul; 245(3):349-360. PubMed ID: 29708271
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined treatment targeting HIF-1α and Stat3 is a potent strategy for prostate cancer therapy.
    Reddy KR; Guan Y; Qin G; Zhou Z; Jing N
    Prostate; 2011 Dec; 71(16):1796-809. PubMed ID: 21480310
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of endothelial PAS domain protein 1 and hypoxia inducible factor 1alpha on vascular endothelial growth factor expression in human pancreatic carcinoma.
    Zhu DM; Li DC; Zhang ZX; Zhang XY
    Chin Med J (Engl); 2008 Nov; 121(22):2258-64. PubMed ID: 19080330
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of hypoxia-inducible factor-1α silencing on drug resistance of human pancreatic cancer cell line Patu8988/5-Fu.
    Yang SY; Song BQ; Dai SL; Yang KX; Jin-Zhou ; Shi KW
    Hepatogastroenterology; 2014; 61(136):2395-401. PubMed ID: 25699390
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypoxia-inducible transcription factor-1alpha promotes hypoxia-induced A549 apoptosis via a mechanism that involves the glycolysis pathway.
    Luo F; Liu X; Yan N; Li S; Cao G; Cheng Q; Xia Q; Wang H
    BMC Cancer; 2006 Jan; 6():26. PubMed ID: 16438736
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protein-bound polysaccharide decreases invasiveness and proliferation in pancreatic cancer by inhibition of hedgehog signaling and HIF-1α pathways under hypoxia.
    Onishi H; Morisaki T; Nakao F; Odate S; Morisaki T; Katano M
    Cancer Lett; 2013 Jul; 335(2):289-98. PubMed ID: 23485726
    [TBL] [Abstract][Full Text] [Related]  

  • 55. SCF, regulated by HIF-1α, promotes pancreatic ductal adenocarcinoma cell progression.
    Gao C; Li S; Zhao T; Chen J; Ren H; Zhang H; Wang X; Lang M; Liu J; Gao S; Zhao X; Sheng J; Yuan Z; Hao J
    PLoS One; 2015; 10(3):e0121338. PubMed ID: 25799412
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of the HIF-1α and NF-κB loop on epithelial-mesenchymal transition and chemoresistance induced by hypoxia in pancreatic cancer cells.
    Cheng ZX; Wang DW; Liu T; Liu WX; Xia WB; Xu J; Zhang YH; Qu YK; Guo LQ; Ding L; Hou J; Zhong ZH
    Oncol Rep; 2014 Apr; 31(4):1891-8. PubMed ID: 24535079
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of small interference RNA targeting HIF-1alpha mediated by rAAV combined L: -ascorbate on pancreatic tumors in athymic mice.
    Chen C; Sun J; Liu G; Chen J
    Pathol Oncol Res; 2009 Mar; 15(1):109-14. PubMed ID: 18509748
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of HIF-1α on glucose metabolism, growth and apoptosis of pancreatic cancerous cells.
    He G; Jiang Y; Zhang B; Wu G
    Asia Pac J Clin Nutr; 2014; 23(1):174-80. PubMed ID: 24561986
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypoxia regulates the expression and localization of CCAAT/enhancer binding protein α by hypoxia inducible factor-1α in bladder transitional carcinoma cells.
    Xue M; Li X; Chen W
    Mol Med Rep; 2015 Aug; 12(2):2121-7. PubMed ID: 25824695
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas.
    Fujiwara S; Nakagawa K; Harada H; Nagato S; Furukawa K; Teraoka M; Seno T; Oka K; Iwata S; Ohnishi T
    Int J Oncol; 2007 Apr; 30(4):793-802. PubMed ID: 17332917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.